RxDoctor Payments DataLook up a doctor →

Elsa Pineda-Flores

Gerontology · Los Angeles, CANPI 1528605961

Payments from drug & device makers

$24,148in general payments, 2019–2025

Across 955 payments — averaging $25.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4K
  • Johnson & Johnson$1K
  • EMD Serono, Inc.$1K
  • Pfizer$1K
  • Merck$1K
  • Bristol Myers Squibb$911
  • plus $15K from 54 others

What the payments were for

  • Consulting fees$8784%
  • Food & beverage$20,12183%
  • Education$1,5536%
  • Other$1,5977%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis110$3,541
Johnson & Johnson56$1,334
EMD Serono, Inc.14$1,210
Pfizer58$1,081
Merck44$1,058
Bristol Myers Squibb57$911
AstraZeneca(2 entities)30$883
Incyte Corporation39$848
Lilly USA, LLC38$802
Bayer35$772
Takeda Pharmaceuticals U.S.A., Inc.22$749
Astellas Pharma US Inc23$680
Karyopharm Therapeutics Inc.23$666
AbbVie34$623
Daiichi Sankyo Inc.26$575
Amgen23$546
Seagen Inc.14$472
Pharmacyclics LLC, An Abbvie Company21$460
Exelixis Inc.15$455
Sanofi18$453
GSK21$401
Gilead(2 entities)19$388
E.r. Squibb & Sons, L.L.C.19$372
Sobi, Inc10$316
Eisai Inc.14$299
Boehringer Ingelheim13$281
Pharmaessentia USA Corporation12$274
Array Biopharma Inc9$228
Deciphera Pharmaceuticals Inc.16$226
Ipsen Biopharmaceuticals, Inc8$202
Stemline Therapeutics Inc.8$197
Beigene USA, Inc.3$182
Taiho Oncology, Inc.7$177
Genentech USA, Inc.6$175
Genmab U.S., Inc.5$161
Blueprint Medicines Corporation6$147
Vantive US Healthcare LLC1$120
Progenics Pharmaceuticals, Inc.5$116
Global Blood Therapeutics, Inc.4$106
Morphosys, US Inc.5$106
Tolmar Pharmaceuticals, Inc.5$104
Adaptive Biotechnologies Corporation5$104
Sun Pharmaceutical Industries Inc.3$88
Sanofi-aventis U.S. LLC1$83
Immunogen, Inc.5$81
Jazz Pharmaceuticals Inc.3$80
Kyowa Kirin, Inc.3$73
Beone Medicines USA, Inc.3$68
Regeneron Healthcare Solutions, Inc.2$67
Novocure Inc.2$64
Geron Corporation2$63
Syndax Pharmaceuticals, Inc.2$60
Acrotech Biopharma Inc.3$57
Azurity Pharmaceuticals, Inc.3$56
Puma Biotechnology, Inc.2$52
Novo Nordisk2$42
Rigel Pharmaceuticals, Inc.2$41
Chiesi USA, Inc.2$36
Emmaus Medical, Inc.2$34
Agios Pharmaceuticals, Inc.1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,148 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$11,281
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$1,543
Megestrol Acetate11$1,206
Anastrozole39$1,057
Letrozole23$550
Alendronate Sodium16$159
Prednisone12$26
Metoprolol Tartrate12$19

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,081$11,28116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 348 gerontology providers in California.

Other gerontology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →